AR and prostate carcinoma: First, it interacts directly with the androgen receptor (AR) and activates its transcriptional activity; however, related studies have shown that AR signaling positively feeds back through the AMPK pathway to induce PGC1α, a signaling pathway axis that controls the metabolic activity of prostate cancer [177].